Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
Apple Inc. (NASDAQ:AAPL) Q2 2024 Earnings Call Transcript May 2, 2024 Apple Inc. beats earnings expectations. Reported EPS is $1.53, expectations were $1.5. Suhasini Chandramouli: Good Afternoon, and welcome to the Apple Q2 Fiscal Year 2024 Earnings Conference Call. My name is Suhasini Chandramouli, Director of Investor Relations. Today’s call is being recorded. Speaking first […]
Apple’s earnings weren’t the disaster some feared and the tech giant even sweetened the deal for investors with a $110 billion stock buyback.